Application 203933
- Type
- ANDA
- Sponsor
- UNIV TX MD ANDERSON
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | AMMONIA N 13 | AMMONIA N-13 | INJECTABLE;INTRAVENOUS | 30mCi-300mCi/8ML (3.75-37.5mCi/ML) | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A203933-001 | AMMONIA N 13 | AMMONIA N-13 | 30mCi-300mCi/8ML (3.75-37.5mCi/ML) | INJECTABLE / INTRAVENOUS | 2014-06-27 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | A203933-001 | AMMONIA N 13 | 30mCi-300mCi/8ML (3.75-37.5mCi/ML) | INJECTABLE / INTRAVENOUS | 2014-06-27 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A203933-001 | AMMONIA N 13 | 30mCi-300mCi/8ML (3.75-37.5mCi/ML) | INJECTABLE / INTRAVENOUS | 2014-06-27 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A203933-001 | AMMONIA N 13 | 30mCi-300mCi/8ML (3.75-37.5mCi/ML) | INJECTABLE / INTRAVENOUS | 2014-06-27 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A203933-001 | AMMONIA N 13 | 30mCi-300mCi/8ML (3.75-37.5mCi/ML) | INJECTABLE / INTRAVENOUS | 2014-06-27 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ammonia N 13 | AMMONIA N-13 | Biomedical Research Foundation of Northwest Louisiana | a4a2bb1a-1ecc-48e4-a87b-60fc583f61ce | 2026-06-10 | Warnings, Adverse reactions | Ammonia N 13 AMMONIA N-13 |
| Ammonia N 13 | AMMONIA N-13 | Ionetix Corporation | 61e196ba-3812-4ffd-8032-12b215378fef | 2026-04-10 | Warnings, Adverse reactions | Ammonia N 13 AMMONIA N-13 |
| Ammonia N 13 | AMMONIA N-13 | Kreitchman PET Center | 26572b37-0999-4c83-8206-1c088026d407 | 2026-01-27 | Adverse reactions | Ammonia N 13 AMMONIA N-13 |
| Ammonia N 13 | AMMONIA N-13 | 3D Imaging Drug Design and Development LLC | fce62c22-a1e2-4193-8de5-e1961d9b94a5 | 2026-01-07 | Warnings, Adverse reactions | Ammonia N 13 AMMONIA N-13 |
| Ammonia N 13 | AMMONIA N-13 | Mayo Clinic | af70d0da-1c2d-44e4-b4cd-7cce6636c7b9 | 2025-12-26 | Warnings, Adverse reactions | Ammonia N 13 AMMONIA N-13 |
| Ammonia N 13 | AMMONIA N-13 | PETNET Solutions, Inc. | b1559f8a-1fc8-4a9e-b4f4-5e2efcb1f12c | 2025-12-03 | Warnings, Adverse reactions | Ammonia N 13 AMMONIA N-13 |
| Ammonia N 13 | NH3N13 | UCSF Radiopharmaceutical Facility | 1f93d72b-6595-4f5f-8ecc-664a612471e5 | 2025-11-14 | Warnings, Adverse reactions | Ammonia N 13 |
| Ammonia N 13 | AMMONIA N 13 | University of Wisconsin System | 730595b1-605c-40a2-8f89-2c3eae98f88a | 2025-10-14 | Warnings, Adverse reactions | Ammonia N 13 |
| Ammonia N 13 | AMMONIA N-13 | SOFIE Co. dba SOFIE | 85882893-0661-46c2-a5f2-a73f6ea4fb5a | 2025-04-03 | Warnings, Adverse reactions | Ammonia N 13 AMMONIA N-13 |
| Ammonia N 13 | AMMONIA N 13 | SOFIE Co. dba SOFIE | d24f8595-2231-4f15-ac2b-9148ec453324 | 2025-04-01 | Warnings, Adverse reactions | Ammonia N 13 |
| AMMONIA N-13 | AMMONIA N-13 | Precision Nuclear LLC | cc430bfd-6940-41ca-bda4-6d29eb4dc1f2 | 2024-12-11 | Warnings, Adverse reactions | AMMONIA N-13 |
| Ammonia N-13 | AMMONIA N-13 | The Methodist Hospital Research Institute | c79222b1-7dd8-f1fe-e053-2a95a90a3639 | 2023-12-19 | Warnings, Adverse reactions | AMMONIA N-13 |
| Ammonia N 13 | AMMONIA N-13 | The University of Texas Southwestern Medical Center | e901d193-527d-4e39-8727-c152b56fb9e2 | 2022-11-17 | Warnings, Adverse reactions | Ammonia N 13 AMMONIA N-13 |
| Ammonia N 13 | AMMONIA N-13 | Massachusetts General Hospital | 57947a8c-939e-4468-805c-2f2001041fe4 | 2021-11-25 | Warnings, Adverse reactions | Ammonia N 13 AMMONIA N-13 |
| AMMONIA N-13 | AMMONIA N-13 | Brigham and Women's Hospital, Inc., The | 3c3c98bd-a052-4564-a15f-37dc6d032707 | 2021-11-03 | Warnings, Adverse reactions | AMMONIA N-13 |
| Ammonia N 13 | NH3N13 | Washington University School of Medicine | 611f4a03-5b6f-420a-925e-adb905bf7b51 | 2021-10-29 | Warnings, Adverse reactions | Ammonia N 13 |
| Ammonia N 13 | NH3N13 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | c857724f-b172-4844-ad42-6fa4c42b0405 | 2019-10-30 | Warnings, Adverse reactions | Ammonia N 13 |
| Ammonia N-13 | AMMONIA N-13 | Cardinal Health 414, LLC | 4c563174-c7cd-4224-b865-4da2f39c21c0 | 2018-07-11 | Warnings, Adverse reactions | AMMONIA N-13 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.